Tilray Inc. ($TLRY) Stock Forecast: Down 11.4% Today

What is Tilray Inc.?

Tilray Brands Inc (NASDAQ: TLRY) is a global leader in medicinal cannabis, focusing on empowering the therapeutic alliance between patients and healthcare practitioners. The stock had a strong bearish movement today amidst recent market developments.

Why is Tilray Inc. going down?

TLRY stock is down 11.4% on Oct 16, 2025 16:45

• A study linking medical cannabis to lower opioid use was likely a positive factor for investors initially.
• However, the company's expansion plans in Panama might not have met market expectations, causing uncertainty among investors.
• The stock's sharp reversal from hitting a new 52-week high could indicate profit-taking by traders, contributing to the bearish movement despite the positive news earlier in the week.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use - Tilray Brands ( NASDAQ:TLRY )

Tilray Brands Inc ( NASDAQ:TLRY ) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here's what investors need to know.

https://www.benzinga.com/trading-ideas/movers/25/10/48239166/tilray-stock-rises-as-study-links-medical-cannabis-to-lower-opioid-use

Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth

NEW YORK, Oct. 13, 2025 ( GLOBE NEWSWIRE ) -- Tilray Medical ( "Tilray" ) , a division of Tilray Brands, Inc. ( NASDAQ: TLRY and TSX: TLRY ) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed ...

https://www.globenewswire.com/news-release/2025/10/13/3165803/0/en/Tilray-Medical-Announces-Expansion-Plans-in-Panama-Strengthening-Global-Cannabis-Leadership-and-Accelerating-International-Growth.html

Tilray Stock Is Sliding Friday: What's Going On? - Tilray Brands ( NASDAQ:TLRY )

Tilray Brands Inc ( NASDAQ:TLRY ) shares are trading lower Friday morning, a sharp reversal after the stock hit a new 52-week high on Thursday. Here's what investors need to know. What To Know: Friday's downturn comes despite the cannabis and consumer goods company reporting impressive ...

https://www.benzinga.com/trading-ideas/movers/25/10/48154343/tilray-stock-is-sliding-friday-whats-going-on

Company News for Oct 10, 2025

Companies in The News Are: ...

https://www.zacks.com/stock/news/2766165/company-news-for-oct-10-2025

Trending Today

ZCash ($ZEC) Crypto Forecast: Up 21.3% Today

1inch ($1INCH) Crypto Forecast: Up 17.9% Today

XRP ($XRP) Crypto Forecast: Down 5.2% Today

Internet Computer ($ICP) Crypto Forecast: Up 43.9% Today

Tezos ($XTZ) Crypto Forecast: Up 16.4% Today

Filecoin ($FIL) Crypto Forecast: Up 50.3% Today

Dash ($DASH) Crypto Forecast: Up 21.3% Today

Solana ($SOL) Crypto Forecast: Down 5.5% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 5.4% Today

Evergy Inc. ($EVRG) Stock Forecast: Down 1.9% Today

Tilray Inc. Price History

10.09.2025 - TLRY Stock was down 15.8%

• The stock's sharp reversal today is possibly due to profit-taking by investors following the recent surge in its price.
• Despite reporting strong earnings and reducing its debt, a shift in market sentiment could have contributed to the bearish movement.
• While the overall market trend was positive on Thursday, with Tilray's stock climbing after good financial results, today's downward movement may indicate a correction or a reaction to the previous day's gains.
• Investors may be reconsidering their positions in Tilray amid market uncertainties, leading to the stock's decline despite a positive earnings surprise in the last quarter.

10.09.2025 - TLRY Stock was down 12.5%

• Even amidst a bearish market environment, Tilray Brands Inc. (TLRY) experienced a remarkable rise in its stock value following the release of break-even earnings for Q1, outperforming analysts' predictions.
• The company's ability to meet and even surpass earnings forecasts, along with a reduction in its debt levels, likely contributed to heightened investor confidence and the subsequent stock price upsurge.
• Investors seemed particularly impressed by Tilray's strong financial performance, including advancements in international cannabis markets, expansions in Europe, and growth within the wellness sector, signaling a positive future for the company.
• The market's response to Tilray's earnings announcement indicates that robust underlying performance can override broader market movements, underscoring the strength and potential of the cannabis industry in the midst of market fluctuations.

09.09.2025 - TLRY Stock was up 25.4%

• The surge in Tilray's stock price followed its release of Q1 earnings, which exceeded projections. This indicates the company's progress in fortifying its financial position and reducing debt.
• Investor response to Tilray's favorable financial performance has been optimistic, reflecting a high level of confidence in the company's achievements.
• Industry analysts believe that Tilray's strategic focus on international cannabis market growth, European market expansion, and advancement in the wellness sector detailed in its Q1 announcement have contributed to the positive market response.
• The decline in short interest concerning Tilray Brands Inc. signifies a shift towards a more optimistic market sentiment among investors, further bolstering the stock's upward movement.

02.09.2025 - TLRY Stock was up 8.0%

• Despite recent market fluctuations, TLRY saw a strong bullish movement, showcasing resilience in the face of broader market trends.
• The surge in TLRY's stock price could be attributed to President Donald Trump's social media post and video highlighting the potential medical benefits of CBD for seniors, sparking investor interest in the company's offerings.
• TLRY's announcement of expanding premium craft cannabis production in Germany and enhancing its medical cannabis portfolio likely contributed to investor optimism and drove the stock's upward momentum.
• The correction observed in TLRY's stock price in previous sessions may have been a natural market adjustment following a significant surge, indicating a healthy consolidation phase for the stock.

09.09.2025 - TLRY Stock was up 20.4%

• TLRY's bullish movement today could be linked to the excitement surrounding its upcoming Q1 earnings report, with investors showing optimism about the company's performance across various segments.
• The decline in short interest as a percent of float might have also influenced the bullish sentiment, suggesting a decrease in bearish positions on the stock and possibly setting the stage for a short squeeze.
• Overall, the favorable market sentiment towards TLRY may be fueled by expectations of robust financial results, ongoing international expansion endeavors, and the potential for growth in the cannabis industry overall.

30.08.2025 - TLRY Stock was up 8.0%

• Tilray revealed plans to expand premium craft cannabis production at its EU-GMP facility in Germany, introducing new patient-centered offerings and showcasing growth and innovation in the cannabis industry.
• President Donald Trump's video highlighting the potential medical benefits of CBD for seniors piqued investor interest in cannabis stocks, including Tilray, amid growing hopes for changes in federal drug policy.
• The general upbeat market sentiment, with the Nasdaq Composite surging over 100 points, also played a role in Tilray's significant stock price increase today.
• Investors are eagerly anticipating Tilray's first-quarter fiscal year 2026 financial results, which could have further implications on the stock's movement in the coming days.

30.08.2025 - TLRY Stock was up 10.1%

• The stock of Tilray rose by over 35% on Monday in response to a statement by a prominent public figure discussing the potential health benefits of CBD for older adults.
• Investor optimism was boosted by Tilray's announcement of an expansion in premium craft cannabis production at its EU-GMP facility in Germany.
• The positive sentiment surrounding Tilray and other cannabis stocks may have been influenced by a recent video by a public figure underscoring the health advantages of cannabis on a social media platform.
• The decline in Tilray's stock price today could be a result of profit-taking after the recent strong gains, as investors review their positions following the significant price increase.

16.09.2025 - TLRY Stock was down 11.4%

• A study linking medical cannabis to lower opioid use was likely a positive factor for investors initially.
• However, the company's expansion plans in Panama might not have met market expectations, causing uncertainty among investors.
• The stock's sharp reversal from hitting a new 52-week high could indicate profit-taking by traders, contributing to the bearish movement despite the positive news earlier in the week.

29.08.2025 - TLRY Stock was up 9.8%

• President Trump's endorsement of the potential health benefits of cannabis on a social media platform ignited optimism in the cannabis industry, leading to a surge in TLRY stock.
• The anticipation of a possible change in federal drug policy under the Trump administration further fueled investor interest in cannabis stocks like TLRY.
• The introduction of Tilray Beverages' new fall seasonal craft brews, including an Oktoberfest-inspired lineup, might have also contributed to positive market sentiment and increased investor confidence in the company's diversified product offerings.

29.08.2025 - TLRY Stock was up 13.7%

• Tilray Brands' stock surged as President Trump's pro-CBD post reignited hopes for a change in federal drug policy, boosting cannabis stocks including TLRY.
• The announcement of Tilray's upcoming financial results for the first quarter of fiscal year 2026 on October 9, 2025, could have also contributed to the positive investor sentiment.
• Additionally, the unveiling of Tilray Beverages' new fall seasonal craft brews with an Oktoberfest-inspired lineup might have attracted investors looking at the company's diversified product offerings and potential for growth in the beverage segment.

14.09.2025 - TLRY Stock was down 5.2%

• The bearish movement in Tilray's stock today could be attributed to profit-taking by investors after a recent surge in the stock price following the better-than-expected first-quarter earnings report.
• The expansion plans in Panama announced by Tilray Medical might not have had an immediate positive impact on the stock price, leading to a sell-off instead.
• The overall market sentiment towards cannabis stocks or sector rotation could have influenced the bearish movement in Tilray's stock, despite the upbeat results reported earlier in the week.
• Investors might be reacting to broader market trends or specific industry news, causing a shift in focus away from Tilray's positive developments towards other opportunities.

01.09.2025 - TLRY Stock was down 6.2%

• Company XYZ's stock witnessed a decline of -6.49% from the previous day's closing price, indicating a significant downturn in the market.
• The decrease in Company XYZ's stock price follows a substantial increase of over 35% on Monday, spurred by a social media discussion mentioning potential medical benefits of CBD for seniors.
• Despite recent positive developments like the expansion of premium craft cannabis production in Germany, today's bearish movement implies that investors may be capitalizing on profits after the previous session's gains.
• The overall market trends and varied performance of U.S. stocks could potentially have motivated traders to adjust their investment portfolios, resulting in downward pressure on Company XYZ's stock.